{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:40:24Z","timestamp":1794260424864,"version":"4.9.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-0996-6","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T13:06:27Z","timestamp":1549544787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review"],"prefix":"10.1186","volume":"14","author":[{"given":"Mercedes","family":"Pineda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Jur\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kolnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Malinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Insua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Velten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"issue":"1","key":"996_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, et al. Consensus clinical management guidelines for Niemann-pick disease type C. Orphanet J Rare Dis. 2018;13(1):50.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"996_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymgme.2016.12.003","volume":"120","author":"E Mengel","year":"2017","unstructured":"Mengel E, Pineda M, Hendriksz CJ, Walterfang M, Torres JV, Kolb SA. Differences in Niemann-pick disease type C symptomatology observed in patients of different ages. Mol Genet Metab. 2017;120(3):180\u20139.","journal-title":"Mol Genet Metab"},{"key":"996_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann-pick disease type C. Orphanet J Rare Dis. 2010;5:16.","journal-title":"Orphanet J Rare Dis."},{"key":"996_CR4","unstructured":"Patterson M. Niemann-Pick Disease Type C. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993-2019"},{"issue":"1","key":"996_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/gim.2015.25","volume":"18","author":"CA Wassif","year":"2016","unstructured":"Wassif CA, Cross JL, Iben J, Sanchez-Pulido L, Cougnoux A, Platt FM, et al. High incidence of unrecognized visceral\/neurological late-onset Niemann-pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18(1):41\u20138.","journal-title":"Genet Med"},{"issue":"23","key":"996_CR6","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","volume":"580","author":"JE Vance","year":"2006","unstructured":"Vance JE. Lipid imbalance in the neurological disorder, Niemann-pick C disease. FEBS Lett. 2006;580(23):5518\u201324.","journal-title":"FEBS Lett"},{"issue":"3","key":"996_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, et al. Recommendations for the diagnosis and management of Niemann-pick disease type C: an update. Mol Genet Metab. 2012;106(3):330\u201344.","journal-title":"Mol Genet Metab"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12887-016-0641-7","volume":"16","author":"M Pineda","year":"2016","unstructured":"Pineda M, Mengel E, Jahnova H, Heron B, Imrie J, Lourenco CM, et al. A suspicion index to aid screening of early-onset Niemann-pick disease type C (NP-C). BMC Pediatr. 2016;16:107.","journal-title":"BMC Pediatr"},{"issue":"1","key":"996_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-013-9626-y","volume":"37","author":"JE Wraith","year":"2014","unstructured":"Wraith JE, Sedel F, Pineda M, Wijburg FA, Hendriksz CJ, Fahey M, et al. Niemann-pick type C suspicion index tool: analyses by age and association of manifestations. J Inherit Metab Dis. 2014;37(1):93\u2013101.","journal-title":"J Inherit Metab Dis"},{"key":"996_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12.","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"996_CR11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","volume":"7","author":"MC Patterson","year":"2017","unstructured":"Patterson MC, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O, et al. Recommendations for the detection and diagnosis of Niemann-pick disease type C: an update. Neurol Clin Pract. 2017;7(6):499\u2013511.","journal-title":"Neurol Clin Pract"},{"issue":"12","key":"996_CR12","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/0883073812464526","volume":"28","author":"P Karimzadeh","year":"2013","unstructured":"Karimzadeh P, Tonekaboni SH, Ashrafi MR, Shafeghati Y, Rezayi A, Salehpour S, et al. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series. J Child Neurol. 2013;28(12):1599\u2013606.","journal-title":"J Child Neurol"},{"issue":"3","key":"996_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","volume":"98","author":"M Pineda","year":"2009","unstructured":"Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, et al. Miglustat in patients with Niemann-pick disease type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab. 2009;98(3):243\u20139.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"996_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","volume":"99","author":"M Pineda","year":"2010","unstructured":"Pineda M, Perez-Poyato MS, O'Callaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-pick disease type C: a case series. Mol Genet Metab. 2010;99(4):358\u201366.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"996_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2006.05.054","volume":"249","author":"C Iturriaga","year":"2006","unstructured":"Iturriaga C, Pineda M, Fernandez-Valero EM, Vanier MT, Coll MJ. Niemann-pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci. 2006;249(1):1\u20136.","journal-title":"J Neurol Sci"},{"issue":"1","key":"996_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK, et al. Linear clinical progression, independent of age of onset, in Niemann-pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132\u201340.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"996_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","volume":"10","author":"S Fecarotta","year":"2015","unstructured":"Fecarotta S, Romano A, Della Casa R, Del Giudice E, Bruschini D, Mansi G, et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-pick disease type C. Orphanet J Rare Dis. 2015;10:22.","journal-title":"Orphanet J Rare Dis."},{"issue":"5","key":"996_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00415-016-8051-1","volume":"263","author":"F Sedel","year":"2016","unstructured":"Sedel F, Chabrol B, Audoin B, Kaphan E, Tranchant C, Burzykowski T, et al. Normalisation of brain spectroscopy findings in Niemann-pick disease type C patients treated with miglustat. J Neurol. 2016;263(5):927\u201336.","journal-title":"J Neurol"},{"key":"996_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1750-1172-8-166","volume":"8","author":"E Mengel","year":"2013","unstructured":"Mengel E, Klunemann HH, Lourenco CM, Hendriksz CJ, Sedel F, Walterfang M, et al. Niemann-pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis. 2013;8:166.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-0996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-0996-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-0996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:26:29Z","timestamp":1720974389000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-0996-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-0996-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained either from the patient, or their parents\/legal guardians according to local laws. The participating site or physician was responsible for obtaining ethical approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MP, KJ, PK and MK have received honoraria for talks and travel reimbursement from Actelion Pharmaceuticals Ltd.VM is has received consultancy fees, honoraria, and travel reimbursement from Actelion Pharmaceuticals Ltd., Alexion Pharma GmbH, Sanofi-Genzyme, and Shire.JLI is an employee of Syntax for Science S.L.CV and SAK are employees of Actelion Pharmaceuticals Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"32"}}